Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCQX - Delayed Quote USD

BioLargo, Inc. (BLGO)

Compare
0.2600
-0.0057
(-2.15%)
At close: March 14 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Dennis P. Calvert Chairman, President & CEO 316.59k -- 1963
Mr. Charles K. Dargan II, C.F.A. Chief Financial Officer -- -- 1955
Mr. Joseph L. Provenzano Executive VP of Operations, Corporate Secretary & Director 223.57k -- 1969
Mr. Kenneth Reay Code Chief Science Officer & Director 301.2k -- 1947
Mr. Alex Evans Director of Corporate Communications -- -- --
Mr. Steven V. Harrison II President of Clyra Medical Technologies Inc 30.24k -- 1959
Mr. Randall Moore President of BioLargo Engineering, Science & Technologies, LLC -- -- --
Dr. Richard Smith Ph.D. President of BioLargo Canada, Inc. -- -- --
Ms. Tonya Chandler President of BioLargo Equipment Solutions & Technologies, Inc. -- -- --

BioLargo, Inc.

14921 Chestnut Street
Westminster, CA 92683
United States
888 400 2863 https://www.biolargo.com
Industry: 
Chemicals
Full Time Employees: 
31

Description

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

Corporate Governance

BioLargo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 31, 2025 at 8:00 PM UTC - April 4, 2025 at 8:00 PM UTC

BioLargo, Inc. Earnings Date

Recent Events

November 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

June 20, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 26, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

April 19, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

Related Tickers